# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-26-187063
Filing Date
2026-04-28
Accepted
2026-04-28 16:13:37
Documents
67
Period of Report
2026-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | dsgn-20260331.htm iXBRL | 10-Q | 2085534
2 | EX-10.1 | dsgn-ex10_1.htm | EX-10.1 | 41030
3 | EX-10.2 | dsgn-ex10_2.htm | EX-10.2 | 91452
4 | EX-31.1 | dsgn-ex31_1.htm | EX-31.1 | 19184
5 | EX-32.1 | dsgn-ex32_1.htm | EX-32.1 | 12971
6 | GRAPHIC | gfx81592623_1.gif | GRAPHIC | 185
7 | GRAPHIC | gfx81592623_0.gif | GRAPHIC | 193
| Complete submission text file | 0001193125-26-187063.txt |  | 7689991

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | dsgn-20260331.xsd | EX-101.SCH | 813598
71 | EXTRACTED XBRL INSTANCE DOCUMENT | dsgn-20260331_htm.xml | XML | 1402474

Mailing Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011
Business Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011 858-293-4900
Design Therapeutics, Inc. (Filer) CIK: 0001807120 (see all company filings)

EIN.: 823929248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40288 | Film No.: 26907927
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)